英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
813909查看　813909　在百度字典中的解释百度英翻中〔查看〕
813909查看　813909　在Google字典中的解释Google英翻中〔查看〕
813909查看　813909　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Pharma companies are taking steps to address access in low . . .
    Five companies in particular have developed and launched inclusive business models with comprehensive approaches to facilitate access to their products for neglected populations, including those in low-income countries and least developed countries
  • Improving Access to Medicines in Low and Middle Income . . .
    In this paper, we make strong public health, human rights and economic arguments for improving access to medicines in LMIC and discuss the different roles and responsibilities of key stakeholders, including national governments, the international community, and non-governmental organizations (NGOs)
  • How Can (Bio)pharmaceutical Companies Contribute to Improving . . .
    (Bio)pharmaceutical companies can improve global access to essential medications in resource-limited settings by adopting several strategies They can implement tiered pricing models to make drugs more affordable in low-income regions and collaborate with governments and non-governmental organizations (NGOs) to strengthen healthcare
  • Pharma’s Opportunity To Impact Health Equity - Oliver Wyman
    While health equity is largely viewed as the domain of governments, providers, and payers, pharmaceutical companies can — and must — play a role in closing gaps in medical access and outcomes In fact, pharmaceutical companies are uniquely positioned to help reduce health disparities
  • Understanding Access Barriers in 2024 and Beyond
    Navigating the landscape of patient access in the pharma industry has become increasingly complex, extending far beyond traditional channels The challenges are multifaceted, influenced by evolving policies, innovative payer strategies, and shifts in provider dynamics
  • Reducing health inequalities and improving access to medicine . . .
    Despite these differences, AAPs are largely designed to overcome the following barriers (see Figure 1): Affordability – a focus on reducing price Activities that lower medicine acquisition cost, either for the patient or the payer Awareness – a focus on supporting the patient
  • Pharma’s dilemma: Cracking the code of access in low- and . . .
    For pharma companies seeking to expand their reach, navigating access in these countries is no longer just about market entry but about addressing systemic barriers like pricing constraints, infrastructure limitations, regulatory complexities and fragmented healthcare systems





中文字典-英文字典  2005-2009